4502

BCR-ABL Quantitative Analysis

Order Code: 4502 Get Requisition Form
Test Information Icon
Test Information
The BCR-ABL assay can be used to monitor minimal residual disease in Philadelphia chromosome positive CML or AML patients being treated with tyrosine kinase inhibitors (TKI).
Disease State Icon
Disease State
Chronic Myelogenous Leukemia
Test Type Icon
Test Type
Genetic Test
Sample Notes Icon
Sample Notes
EDTA Bone Marrow (lavender top) or EDTA Whole Blood (lavender top) or Total RNA (frozen)
Requested Volume Icon
Requested Volume
3-5 ml EDTA Bone Marrow (lavender top) or 10 ml EDTA Whole Blood (lavender top) or frozen Total RNA
Additional Sample Information Icon
Additional Sample Information
Sample must be received within 48 hours of collection. Indicate on specimen tube and requisition whether sample is whole blood or bone marrow.
Shipping Information Icon
Shipping Information
Room Temperature or Frozen if Total RNA
CPT Codes Icon
CPT Codes
  • 81206
Method Icon
Method
Quantitative Real-Time PCR
Turnaround Time Icon
Turnaround Time
3-6 days
New York State Approval Icon
New York State Approval
Approved
DEX Z-Code™ Icon
DEX Z-Code™
No
 
Our Experts
Research investigators, postdoctoral fellows and laboratory staff at Versiti Blood Research Institute and Diagnostic Laboratories.
 
Molecular Oncology Testing
Molecular oncology lab tests to help diagnose blood cancers like acute myeloid leukemia, chronic myelogenous leukemia and more.
 
Requisitions
Access requisitions for Versiti Diagnostic Laboratories.